People with untreated sleep apnea face more than 3x the risk of premature death and more than 5xthe risk of cardiovascular mortality.
of all patients diagnosed with sleep apnea and prescribed CPAP therapy will abandon treatment or fail on CPAP.
$65 – $165B
Estimated total annual economic costof moderate to severe OSA in the U.S. This is greater than asthma, heart failure, stroke and hypertensive disease ($20-$80B).
Young, T., Finn, L., Peppard, P.E., et al. Sleep Disordered Breathing and Mortality: Eighteen-Year Follow-up of the Wisconsin Sleep Cohort. Sleep. Sleep Research Society. 2008 Aug 1; 31(8): 1071-1078 American Sleep Apnea Association. CPAP Therapy, Attitude, and Expectations. Can Respir J. Long-term compliance with continuous positive airway pressure in patients with obstructive sleep apnea. Canadian Respiratory Journal 2008 Oct; 15(7): 365–369. Harvard Medical School Division of Sleep Medicine, The price of fatigue; The surprising economic costs of unmanaged sleep apnea, December 2010 Sutherland K, Phillips CL, Cistulli PA, Efficacy versus effectiveness in the treatment of obstructive sleep apnea. CPAP and oral appliances. Journal of Dental Sleep Medicine 2015, 2(4) 175-181
©2021 XII Medical. All rights reserved.